Sanofi and Regeneron's medical congress campaign focuses on type 2 inflammation education for docs

As Sanofi Genzyme and Regeneron continue to add indications for their next-gen immunology treatment Dupixent, the partners have created a separate unbranded campaign—called “Type 2 Inflammation Connection”—to raise overall awareness about type 2 inflammation and its connections across multiple diseases and conditions.